NHS Introduces Quick MS Injection to Replace Lengthy Infusions

The new 10-minute jab for multiple sclerosis patients will significantly reduce hospital time and improve treatment convenience.

The injection, ocrelizumab, can be administered in 10 minutes compared to the current four-hour infusion process.
It is expected to benefit around 9,000 MS patients in England, Wales, and Northern Ireland.
The new method has been approved by the Medicines and Healthcare products Regulatory Agency and will be available within weeks.
Ocrelizumab targets B cells to reduce the immune response that damages nerve coverings in MS patients.
The change is anticipated to free up hospital resources and allow more time for clinicians to treat additional patients.